DONATE

Free Support Line: 833-275-4222

Walk to End Bladder Cancer

BCAN’s Partners in Progress

Each month during 2025, our 20th anniversary, BCAN is proud to spotlight a pharmaceutical company partner that has shown outstanding commitment to supporting bladder cancer patients and their families. These dedicated partners play a vital role in advancing research, raising awareness, and improving the lives of those impacted by bladder cancer. Through their collaboration and shared vision, we continue to make strides toward better treatments, enhanced care, and hope for a brighter future.

Click below to learn more about each partner’s commitment.

Partners in Progress

  • January – Ferring Pharmaceuticals

    Ferring Uro-Oncology is guided by a deep commitment to bringing hope and healing to patients diagnosed with bladder cancer.  Learn more here.

  • February – Photocure

    Recognizing the limitations faced by bladder cancer patients, Photocure strives to be “The Bladder Cancer Company,” prioritizing patient-centric solutions. Learn more here.

  • March – Ferring Uro-oncology

    Ferring Pharmaceuticals demonstrates a strong commitment to bladder cancer patients and families through their development of innovative therapies.  Learn more here.

Thank you to all 2025 Partners in Progress sponsors for their generous support including the Astellas/Pfizer Alliance, CG Oncology, EMD Serono, Ferring Pharmaceuticals, Johnson and Johnson, Photocure and Urogen.

Related Stories